Please use this identifier to cite or link to this item: http://nopr.niscpr.res.in/handle/123456789/66446
Full metadata record
DC FieldValueLanguage
dc.contributor.authorThaorey, Payal-
dc.contributor.authorMukte, Anushree-
dc.date.accessioned2025-09-12T10:15:34Z-
dc.date.available2025-09-12T10:15:34Z-
dc.date.issued2025-09-
dc.identifier.issn0975-1076 (Online); 0971-7544 (Print)-
dc.identifier.urihttp://nopr.niscpr.res.in/handle/123456789/66446-
dc.description537-549en_US
dc.description.abstractPublic policy, right to health, affordable medicines and patenting of medicines are closely knitted phenomena for fulfilment of individual and public interest imperatives. This article attempts to analyse the impact of patenting and commercialization of the medicines with and against materialization of right to health for all. The welfare aspects public policy that provides for availability and affordability of medicines for all and its applicability with respect to patenting and commercialization of medicines is examined in light of specific issues as followsi. Primarily, whether the existing patent policy in specific is responsive to public policy in general. ii. Secondly, to what extent public policy shall be incorporated in commercialization of pharmaceutical patents? iii. Thirdly, to what extent commercialization of pharmaceutical patents can be compromised for execution of public policy? iv. Fourthly, is there any possibility of balancing mechanism wherein both, commercialization and public policy with respect to pharmaceutical patents can be maintained?en_US
dc.language.isoenen_US
dc.publisherNIScPR-CSIR, Indiaen_US
dc.sourceJIPR Vol.30(5) [September 2025]en_US
dc.subjectIntellectual Property Rightsen_US
dc.subjectPatentsen_US
dc.subjectPharmaceutical Patentsen_US
dc.subjectIndiaen_US
dc.subjectPublic Policyen_US
dc.subjectRight to Healthen_US
dc.subjectCommercialization of Pharmaceutical Patentsen_US
dc.subjectCompulsory Licensingen_US
dc.subjectAffordability of Medicinesen_US
dc.subjectEconomic- Monopolistic Approach of Patenten_US
dc.titlePublic Policy Reflection on Commercialization of Pharmaceutical Patents in India: A Legal Introspecten_US
dc.typeArticleen_US
dc.identifier.doihttps://doi.org/10.56042/jipr.v30i5.7865en_US
Appears in Collections:JIPR Vol.30(5) [September 2025]

Files in This Item:
File Description SizeFormat 
JIPR-30(5) 537-549.pdf272.68 kBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.